Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| MACROGENICS INCMGNX · Entity 6104 | Director · President and CEO | February 12, 2026 | February 17, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
MACROGENICS INC
Report date February 12, 2026 · Filed February 17, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 77,169 |
Ending reported balance
After 2026-02-15 transaction · row 2
2 source rows · reconciled sequenceRow 1 · 2026-02-15 · Exercise / conversion · Acquired 16,665 · Balance 83,602 F1: On February 15, 2023, the reporting person was granted 50,000 restricted stock units, vesting in three equal annual installments beginning on the first anniversary of the grant date. Restricted stock units convert into the Company's stock on a one-for-one basis. Row 2 · 2026-02-15 · Tax withholding · Disposed 6,433 · Balance 77,169 |
| Restricted Stock UnitSEC Table II · derivative / convertible security | Direct | 0 |
Reported balance
After 2026-02-15 transaction · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · 2026-02-15 · Exercise / conversion · Disposed 16,665 · Balance 0 F1: On February 15, 2023, the reporting person was granted 50,000 restricted stock units, vesting in three equal annual installments beginning on the first anniversary of the grant date. Restricted stock units convert into the Company's stock on a one-for-one basis. |
| Restricted Stock UnitSEC Table II · derivative / convertible security | Direct | 100,000 |
Reported balance
After 2026-02-12 transaction · row 4
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 4 · 2026-02-12 · Grant · Acquired 100,000 · Balance 100,000 F2: Each restricted stock unit (RSU) represents a contingent right to receive one share of the Issuer's common stock. The RSUs will vest as to 33% of the total shares one year after the date of grant and 33% each year thereafter. |
| Employee Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $1.71 · Expires 2036-02-12 | Direct | 595,000 |
Reported balance
After 2026-02-12 transaction · row 5
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 5 · 2026-02-12 · Grant · Acquired 595,000 · Balance 595,000 F3: 12.5% of the shares underlying the grant became exercisable one year after the date of grant and an additional 6.25% of the shares underlying the grant became exercisable on the first day of each three-month period thereafter. |
Filing footnotes · ownership attribution and instrument terms
F1: On February 15, 2023, the reporting person was granted 50,000 restricted stock units, vesting in three equal annual installments beginning on the first anniversary of the grant date. Restricted stock units convert into the Company's stock on a one-for-one basis.
F2: Each restricted stock unit (RSU) represents a contingent right to receive one share of the Issuer's common stock. The RSUs will vest as to 33% of the total shares one year after the date of grant and 33% each year thereafter.
F3: 12.5% of the shares underlying the grant became exercisable one year after the date of grant and an additional 6.25% of the shares underlying the grant became exercisable on the first day of each three-month period thereafter.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| August 26, 2020 Filed Aug 27, 2020 21:04 UTC | MACROGENICS INC MGNX · Entity 6104 | SaleCommon Stock | 500 | $27.10 | $13,549.50 |
DisclosureSEC source: 0001125345-20-000131 · wf-form4_159856225437104.xml · nonDerivative · entry 2 Risser Eric Blasius · CIK 0001587774 · Sr VP & Chief Business Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 44,468 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 5, 2019. F2 · price: This transaction was executed in multiple trades at prices ranging from $26.62 to $27.40. The reporting person undertakes to provide to MacroGenics, Inc., any security holder of MacroGenics, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. Read SEC document |
| August 26, 2020 Filed Aug 27, 2020 21:04 UTC | MACROGENICS INC MGNX · Entity 6104 | Exercise / conversionCommon Stock | 500 | $1.51 | $755.00 |
DisclosureSEC source: 0001125345-20-000131 · wf-form4_159856225437104.xml · nonDerivative · entry 1 Risser Eric Blasius · CIK 0001587774 · Sr VP & Chief Business Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 44,968 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| July 27, 2020 Filed Jul 28, 2020 21:12 UTC | MACROGENICS INC MGNX · Entity 6104 | Exercise / conversionEmployee stock option (right to buy) · Derivative | 4,000 | $0.00 Strike: $1.51 | $0.00 |
DisclosureSEC source: 0001125345-20-000118 · wf-form4_159597054259461.xml · derivative · entry 7 Risser Eric Blasius · CIK 0001587774 · Sr VP & Chief Business Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,000 Underlying: Common Stock · 4,000 shares Expires 2023-01-05 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| July 27, 2020 Filed Jul 28, 2020 21:12 UTC | MACROGENICS INC MGNX · Entity 6104 | Exercise / conversionEmployee stock option (right to buy) · Derivative | 489 | $0.00 Strike: $0.94 | $0.00 |
DisclosureSEC source: 0001125345-20-000118 · wf-form4_159597054259461.xml · derivative · entry 6 Risser Eric Blasius · CIK 0001587774 · Sr VP & Chief Business Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 489 shares Expires 2021-01-08 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| July 27, 2020 Filed Jul 28, 2020 21:12 UTC | MACROGENICS INC MGNX · Entity 6104 | SaleCommon Stock | 3,000 | $25.63 | $76,890.00 |
DisclosureSEC source: 0001125345-20-000118 · wf-form4_159597054259461.xml · nonDerivative · entry 5 Risser Eric Blasius · CIK 0001587774 · Sr VP & Chief Business Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 44,468 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 5, 2019. F4 · price: This transaction was executed in multiple trades at prices ranging from $24.71 to $26.15. The reporting person undertakes to provide to MacroGenics, Inc., any security holder of MacroGenics, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. Read SEC document |
| July 27, 2020 Filed Jul 28, 2020 21:12 UTC | MACROGENICS INC MGNX · Entity 6104 | SaleCommon Stock | 1,000 | $25.14 | $25,140.00 |
DisclosureSEC source: 0001125345-20-000118 · wf-form4_159597054259461.xml · nonDerivative · entry 4 Risser Eric Blasius · CIK 0001587774 · Sr VP & Chief Business Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 47,468 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 5, 2019. F3 · price: This transaction was executed in multiple trades at prices ranging from $24.72 to $25.55. The reporting person undertakes to provide to MacroGenics, Inc., any security holder of MacroGenics, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. Read SEC document |
| July 27, 2020 Filed Jul 28, 2020 21:12 UTC | MACROGENICS INC MGNX · Entity 6104 | Exercise / conversionCommon Stock | 4,000 | $1.51 | $6,040.00 |
DisclosureSEC source: 0001125345-20-000118 · wf-form4_159597054259461.xml · nonDerivative · entry 3 Risser Eric Blasius · CIK 0001587774 · Sr VP & Chief Business Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 48,468 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| July 27, 2020 Filed Jul 28, 2020 21:12 UTC | MACROGENICS INC MGNX · Entity 6104 | SaleCommon Stock | 489 | $25.13 | $12,288.57 |
DisclosureSEC source: 0001125345-20-000118 · wf-form4_159597054259461.xml · nonDerivative · entry 2 Risser Eric Blasius · CIK 0001587774 · Sr VP & Chief Business Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 44,468 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 5, 2019. F2 · price: This transaction was executed in multiple trades at prices ranging from $25.01 to $25.21. The reporting person undertakes to provide to MacroGenics, Inc., any security holder of MacroGenics, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. Read SEC document |
| July 27, 2020 Filed Jul 28, 2020 21:12 UTC | MACROGENICS INC MGNX · Entity 6104 | Exercise / conversionCommon Stock | 489 | $0.94 | $459.66 |
DisclosureSEC source: 0001125345-20-000118 · wf-form4_159597054259461.xml · nonDerivative · entry 1 Risser Eric Blasius · CIK 0001587774 · Sr VP & Chief Business Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 44,957 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| July 02, 2020 Filed Jul 6, 2020 20:25 UTC | MACROGENICS INC MGNX · Entity 6104 | Exercise / conversionEmployee stock option (right to buy) · Derivative | 3,100 | $0.00 Strike: $1.51 | $0.00 |
DisclosureSEC source: 0001125345-20-000115 · wf-form4_159406709977419.xml · derivative · entry 3 Risser Eric Blasius · CIK 0001587774 · Sr VP & Chief Business Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,000 Underlying: Common Stock · 3,100 shares Expires 2023-01-05 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| July 02, 2020 Filed Jul 6, 2020 20:25 UTC | MACROGENICS INC MGNX · Entity 6104 | SaleCommon Stock | 3,100 | $30.00 | $93,000.00 |
DisclosureSEC source: 0001125345-20-000115 · wf-form4_159406709977419.xml · nonDerivative · entry 2 Risser Eric Blasius · CIK 0001587774 · Sr VP & Chief Business Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 44,468 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 5, 2019. Read SEC document |
| July 02, 2020 Filed Jul 6, 2020 20:25 UTC | MACROGENICS INC MGNX · Entity 6104 | Exercise / conversionCommon Stock | 3,100 | $1.51 | $4,681.00 |
DisclosureSEC source: 0001125345-20-000115 · wf-form4_159406709977419.xml · nonDerivative · entry 1 Risser Eric Blasius · CIK 0001587774 · Sr VP & Chief Business Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 47,568 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 24, 2020 Filed Jun 25, 2020 20:57 UTC | MACROGENICS INC MGNX · Entity 6104 | Exercise / conversionEmployee stock option (right to buy) · Derivative | 500 | $0.00 Strike: $0.94 | $0.00 |
DisclosureSEC source: 0001125345-20-000108 · wf-form4_159311863890623.xml · derivative · entry 3 Risser Eric Blasius · CIK 0001587774 · Sr VP & Chief Business Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 489 Underlying: Common Stock · 500 shares Expires 2021-01-08 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 24, 2020 Filed Jun 25, 2020 20:57 UTC | MACROGENICS INC MGNX · Entity 6104 | SaleCommon Stock | 500 | $28.49 | $14,245.00 |
DisclosureSEC source: 0001125345-20-000108 · wf-form4_159311863890623.xml · nonDerivative · entry 2 Risser Eric Blasius · CIK 0001587774 · Sr VP & Chief Business Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 44,468 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 5, 2019. Read SEC document |
| June 24, 2020 Filed Jun 25, 2020 20:57 UTC | MACROGENICS INC MGNX · Entity 6104 | Exercise / conversionCommon Stock | 500 | $0.94 | $470.00 |
DisclosureSEC source: 0001125345-20-000108 · wf-form4_159311863890623.xml · nonDerivative · entry 1 Risser Eric Blasius · CIK 0001587774 · Sr VP & Chief Business Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 44,968 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 26, 2020 Filed May 27, 2020 20:43 UTC | MACROGENICS INC MGNX · Entity 6104 | Exercise / conversionEmployee stock option (right to buy) · Derivative | 500 | $0.00 Strike: $0.94 | $0.00 |
DisclosureSEC source: 0001125345-20-000100 · wf-form4_159061217316217.xml · derivative · entry 3 Risser Eric Blasius · CIK 0001587774 · Sr VP & Chief Business Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 989 Underlying: Common Stock · 500 shares Expires 2021-01-08 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 26, 2020 Filed May 27, 2020 20:43 UTC | MACROGENICS INC MGNX · Entity 6104 | SaleCommon Stock | 500 | $26.59 | $13,295.00 |
DisclosureSEC source: 0001125345-20-000100 · wf-form4_159061217316217.xml · nonDerivative · entry 2 Risser Eric Blasius · CIK 0001587774 · Sr VP & Chief Business Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 44,468 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 5, 2019. F2 · price: This transaction was executed in multiple trades at prices ranging from $26.52 to $26.66. The reporting person undertakes to provide to MacroGenics, Inc., any security holder of MacroGenics, Inc., or the staffof the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. Read SEC document |
| May 26, 2020 Filed May 27, 2020 20:43 UTC | MACROGENICS INC MGNX · Entity 6104 | Exercise / conversionCommon Stock | 500 | $0.94 | $470.00 |
DisclosureSEC source: 0001125345-20-000100 · wf-form4_159061217316217.xml · nonDerivative · entry 1 Risser Eric Blasius · CIK 0001587774 · Sr VP & Chief Business Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 44,968 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 06, 2020 Filed May 7, 2020 20:22 UTC | MACROGENICS INC MGNX · Entity 6104 | Exercise / conversionEmployee stock option (right to buy) · Derivative | 7,532 | $1.51 Strike: $1.51 | $11,373.32 |
DisclosureSEC source: 0001125345-20-000075 · wf-form4_158888294604504.xml · derivative · entry 8 Risser Eric Blasius · CIK 0001587774 · Sr VP & Chief Business Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,100 Underlying: Common Stock · 7,532 shares Expires 2023-01-05 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 06, 2020 Filed May 7, 2020 20:22 UTC | MACROGENICS INC MGNX · Entity 6104 | Exercise / conversionEmployee stock option (right to buy) · Derivative | 500 | $0.94 Strike: $0.94 | $470.00 |
DisclosureSEC source: 0001125345-20-000075 · wf-form4_158888294604504.xml · derivative · entry 7 Risser Eric Blasius · CIK 0001587774 · Sr VP & Chief Business Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,489 Underlying: Common Stock · 500 shares Expires 2021-01-08 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 06, 2020 Filed May 7, 2020 20:22 UTC | MACROGENICS INC MGNX · Entity 6104 | SaleCommon Stock | 3,532 | $25.00 | $88,300.00 |
DisclosureSEC source: 0001125345-20-000075 · wf-form4_158888294604504.xml · nonDerivative · entry 6 Risser Eric Blasius · CIK 0001587774 · Sr VP & Chief Business Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 44,468 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 5, 2019. Read SEC document |
| May 06, 2020 Filed May 7, 2020 20:22 UTC | MACROGENICS INC MGNX · Entity 6104 | SaleCommon Stock | 3,000 | $20.00 | $60,000.00 |
DisclosureSEC source: 0001125345-20-000075 · wf-form4_158888294604504.xml · nonDerivative · entry 5 Risser Eric Blasius · CIK 0001587774 · Sr VP & Chief Business Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 48,000 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 5, 2019. Read SEC document |
| May 06, 2020 Filed May 7, 2020 20:22 UTC | MACROGENICS INC MGNX · Entity 6104 | SaleCommon Stock | 1,000 | $15.00 | $15,000.00 |
DisclosureSEC source: 0001125345-20-000075 · wf-form4_158888294604504.xml · nonDerivative · entry 4 Risser Eric Blasius · CIK 0001587774 · Sr VP & Chief Business Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 51,000 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 5, 2019. Read SEC document |
| May 06, 2020 Filed May 7, 2020 20:22 UTC | MACROGENICS INC MGNX · Entity 6104 | SaleCommon Stock | 500 | $10.00 | $5,000.00 |
DisclosureSEC source: 0001125345-20-000075 · wf-form4_158888294604504.xml · nonDerivative · entry 3 Risser Eric Blasius · CIK 0001587774 · Sr VP & Chief Business Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 52,000 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 5, 2019. Read SEC document |
| May 06, 2020 Filed May 7, 2020 20:22 UTC | MACROGENICS INC MGNX · Entity 6104 | Exercise / conversionCommon Stock | 7,532 | $1.51 | $11,373.32 |
DisclosureSEC source: 0001125345-20-000075 · wf-form4_158888294604504.xml · nonDerivative · entry 2 Risser Eric Blasius · CIK 0001587774 · Sr VP & Chief Business Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 52,500 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 06, 2020 Filed May 7, 2020 20:22 UTC | MACROGENICS INC MGNX · Entity 6104 | Exercise / conversionCommon Stock | 500 | $0.94 | $470.00 |
DisclosureSEC source: 0001125345-20-000075 · wf-form4_158888294604504.xml · nonDerivative · entry 1 Risser Eric Blasius · CIK 0001587774 · Sr VP & Chief Business Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 44,968 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| April 16, 2020 Filed Apr 17, 2020 20:11 UTC | MACROGENICS INC MGNX · Entity 6104 | Exercise / conversionEmployee stock option (right to buy) · Derivative | 6,000 | $0.94 Strike: $0.94 | $5,640.00 |
DisclosureSEC source: 0001125345-20-000059 · wf-form4_158715426128615.xml · derivative · entry 2 Risser Eric Blasius · CIK 0001587774 · Sr VP & Chief Business Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,989 Underlying: Common Stock · 6,000 shares Expires 2021-01-08 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| April 16, 2020 Filed Apr 17, 2020 20:11 UTC | MACROGENICS INC MGNX · Entity 6104 | Exercise / conversionCommon Stock | 6,000 | $0.94 | $5,640.00 |
DisclosureSEC source: 0001125345-20-000059 · wf-form4_158715426128615.xml · nonDerivative · entry 1 Risser Eric Blasius · CIK 0001587774 · Sr VP & Chief Business Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 44,468 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 13, 2020 Filed Mar 17, 2020 20:09 UTC | MACROGENICS INC MGNX · Entity 6104 | Exercise / conversionEmployee stock option (right to buy) · Derivative | 6,000 | $0.94 Strike: $0.94 | $5,640.00 |
DisclosureSEC source: 0001125345-20-000046 · wf-form4_158447577366938.xml · derivative · entry 2 Risser Eric Blasius · CIK 0001587774 · Sr VP & Chief Business Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 500 Underlying: Common Stock · 6,000 shares Expires 2022-03-13 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 13, 2020 Filed Mar 17, 2020 20:09 UTC | MACROGENICS INC MGNX · Entity 6104 | Exercise / conversionCommon Stock | 6,000 | $0.94 | $5,640.00 |
DisclosureSEC source: 0001125345-20-000046 · wf-form4_158447577366938.xml · nonDerivative · entry 1 Risser Eric Blasius · CIK 0001587774 · Sr VP & Chief Business Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 38,468 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 20, 2020 Filed Feb 21, 2020 21:44 UTC | MACROGENICS INC MGNX · Entity 6104 | Exercise / conversionEmployee stock option (right to buy) · Derivative | 500 | $0.94 Strike: $0.94 | $470.00 |
DisclosureSEC source: 0001125345-20-000011 · wf-form4_158232147185800.xml · derivative · entry 3 Risser Eric Blasius · CIK 0001587774 · Sr VP & Chief Business Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,500 Underlying: Common Stock · 500 shares Expires 2022-03-13 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 20, 2020 Filed Feb 21, 2020 21:44 UTC | MACROGENICS INC MGNX · Entity 6104 | SaleCommon Stock | 500 | $10.84 | $5,420.00 |
DisclosureSEC source: 0001125345-20-000011 · wf-form4_158232147185800.xml · nonDerivative · entry 2 Risser Eric Blasius · CIK 0001587774 · Sr VP & Chief Business Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 32,468 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 5, 2019. Read SEC document |
| February 20, 2020 Filed Feb 21, 2020 21:44 UTC | MACROGENICS INC MGNX · Entity 6104 | Exercise / conversionCommon Stock | 500 | $0.94 | $470.00 |
DisclosureSEC source: 0001125345-20-000011 · wf-form4_158232147185800.xml · nonDerivative · entry 1 Risser Eric Blasius · CIK 0001587774 · Sr VP & Chief Business Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 32,968 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 20, 2020 Filed Feb 24, 2020 21:46 UTC | MACROGENICS INC MGNX · Entity 6104 | GrantEmployee stock option (right to buy) · Derivative | 90,000 | $11.50 Strike: $11.50 | $1,035,000.00 |
DisclosureSEC source: 0001125345-20-000023 · wf-form4_158258075393547.xml · derivative · entry 1 Risser Eric Blasius · CIK 0001587774 · Sr VP & Chief Business Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 90,000 Underlying: Common Stock · 90,000 shares Expires 2030-02-20 F1 · derivative.exercise_date: 12.5% of the options become exercisable 6 months after the date of grant and the remaining 87.5% shall vest in 14 substantially equal quarterly installments thereafter. Read SEC document |
| February 05, 2020 Filed Feb 6, 2020 21:41 UTC | MACROGENICS INC MGNX · Entity 6104 | Exercise / conversionEmployee stock option (right to buy) · Derivative | 623 | $0.94 Strike: $0.94 | $585.62 |
DisclosureSEC source: 0001125345-20-000009 · wf-form4_158102526689957.xml · derivative · entry 6 Risser Eric Blasius · CIK 0001587774 · Sr VP & Chief Business Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,000 Underlying: Common Stock · 623 shares Expires 2022-03-13 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 05, 2020 Filed Feb 6, 2020 21:41 UTC | MACROGENICS INC MGNX · Entity 6104 | SaleCommon Stock | 623 | $10.00 | $6,230.00 |
DisclosureSEC source: 0001125345-20-000009 · wf-form4_158102526689957.xml · nonDerivative · entry 4 Risser Eric Blasius · CIK 0001587774 · Sr VP & Chief Business Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 32,468 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 5, 2019. Read SEC document |
| February 05, 2020 Filed Feb 6, 2020 21:41 UTC | MACROGENICS INC MGNX · Entity 6104 | Exercise / conversionCommon Stock | 623 | $0.94 | $585.62 |
DisclosureSEC source: 0001125345-20-000009 · wf-form4_158102526689957.xml · nonDerivative · entry 3 Risser Eric Blasius · CIK 0001587774 · Sr VP & Chief Business Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 33,091 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 04, 2020 Filed Feb 6, 2020 21:41 UTC | MACROGENICS INC MGNX · Entity 6104 | Exercise / conversionEmployee stock option (right to buy) · Derivative | 30 | $0.94 Strike: $0.94 | $28.20 |
DisclosureSEC source: 0001125345-20-000009 · wf-form4_158102526689957.xml · derivative · entry 5 Risser Eric Blasius · CIK 0001587774 · Sr VP & Chief Business Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,623 Underlying: Common Stock · 30 shares Expires 2022-03-13 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 04, 2020 Filed Feb 6, 2020 21:41 UTC | MACROGENICS INC MGNX · Entity 6104 | SaleCommon Stock | 30 | $10.00 | $300.00 |
DisclosureSEC source: 0001125345-20-000009 · wf-form4_158102526689957.xml · nonDerivative · entry 2 Risser Eric Blasius · CIK 0001587774 · Sr VP & Chief Business Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 32,468 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 5, 2019. Read SEC document |
| February 04, 2020 Filed Feb 6, 2020 21:41 UTC | MACROGENICS INC MGNX · Entity 6104 | Exercise / conversionCommon Stock | 30 | $0.94 | $28.20 |
DisclosureSEC source: 0001125345-20-000009 · wf-form4_158102526689957.xml · nonDerivative · entry 1 Risser Eric Blasius · CIK 0001587774 · Sr VP & Chief Business Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 32,498 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 27, 2019 Filed Oct 3, 2019 20:33 UTC | MACROGENICS INC MGNX · Entity 6104 | Exercise / conversionStock Option (right to buy) · Derivative | 1,662 | $0.00 Strike: $0.94 | $0.00 |
DisclosureSEC source: 0001125345-19-000100 · wf-form4_157013477244564.xml · derivative · entry 2 Risser Eric Blasius · CIK 0001587774 · Sr VP & Chief Business Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,662 shares Expires 2020-01-09 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transaction represents an exercise and hold of expiring options. Read SEC document |
| September 27, 2019 Filed Oct 3, 2019 20:33 UTC | MACROGENICS INC MGNX · Entity 6104 | Exercise / conversionCommon Stock | 1,662 | $0.94 | $1,562.28 |
DisclosureSEC source: 0001125345-19-000100 · wf-form4_157013477244564.xml · nonDerivative · entry 1 Risser Eric Blasius · CIK 0001587774 · Sr VP & Chief Business Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 32,468 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 22, 2019 Filed May 22, 2019 20:21 UTC | MACROGENICS INC MGNX · Entity 6104 | Exercise / conversionStock Option (right to buy) · Derivative | 1,000 | $0.00 Strike: $0.94 | $0.00 |
DisclosureSEC source: 0001125345-19-000083 · wf-form4_155855647815200.xml · derivative · entry 6 Risser Eric Blasius · CIK 0001587774 · Sr VP & Chief Business Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,662 Underlying: Common Stock · 1,000 shares Expires 2020-01-09 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 22, 2019 Filed May 22, 2019 20:21 UTC | MACROGENICS INC MGNX · Entity 6104 | SaleCommon Stock | 1,000 | $19.03 | $19,026.00 |
DisclosureSEC source: 0001125345-19-000083 · wf-form4_155855647815200.xml · nonDerivative · entry 4 Risser Eric Blasius · CIK 0001587774 · Sr VP & Chief Business Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,806 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 14, 2019. F3 · price: The price reported in column 4 is a weighted-average price. These shares were purchased in multiple transactions at prices ranging from $19.00 to $19.026. The reporting person will provide to the Issuer, any security holder of the Issuer or the SEC staff, upon request, information regarding the number of shares purchased at each price within the range. Read SEC document |
| May 22, 2019 Filed May 22, 2019 20:21 UTC | MACROGENICS INC MGNX · Entity 6104 | Exercise / conversionCommon Stock | 1,000 | $0.94 | $940.00 |
DisclosureSEC source: 0001125345-19-000083 · wf-form4_155855647815200.xml · nonDerivative · entry 3 Risser Eric Blasius · CIK 0001587774 · Sr VP & Chief Business Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 31,806 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 20, 2019 Filed May 22, 2019 20:21 UTC | MACROGENICS INC MGNX · Entity 6104 | Exercise / conversionEmployee stock option (right to buy) · Derivative | 3,000 | $0.00 Strike: $0.94 | $0.00 |
DisclosureSEC source: 0001125345-19-000083 · wf-form4_155855647815200.xml · derivative · entry 5 Risser Eric Blasius · CIK 0001587774 · Sr VP & Chief Business Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,653 Underlying: Common Stock · 3,000 shares Expires 2022-03-13 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 20, 2019 Filed May 22, 2019 20:21 UTC | MACROGENICS INC MGNX · Entity 6104 | SaleCommon Stock | 3,000 | $18.38 | $55,131.00 |
DisclosureSEC source: 0001125345-19-000083 · wf-form4_155855647815200.xml · nonDerivative · entry 2 Risser Eric Blasius · CIK 0001587774 · Sr VP & Chief Business Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,806 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 14, 2019. F2 · price: The price reported in column 4 is a weighted-average price. These shares were purchased in multiple transactions at prices ranging from $18.25 to $18.50. The reporting person will provide to the Issuer, any security holder of the Issuer or the SEC staff, upon request, information regarding the number of shares purchased at each price within the range. Read SEC document |
| May 20, 2019 Filed May 22, 2019 20:21 UTC | MACROGENICS INC MGNX · Entity 6104 | Exercise / conversionCommon Stock | 3,000 | $0.94 | $2,820.00 |
DisclosureSEC source: 0001125345-19-000083 · wf-form4_155855647815200.xml · nonDerivative · entry 1 Risser Eric Blasius · CIK 0001587774 · Sr VP & Chief Business Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 33,806 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 14, 2019 Filed Mar 18, 2019 20:36 UTC | MACROGENICS INC MGNX · Entity 6104 | Exercise / conversionEmployee stock option (right to buy) · Derivative | 2,497 | $0.00 Strike: $0.94 | $0.00 |
DisclosureSEC source: 0001125345-19-000050 · wf-form4_155294139184437.xml · derivative · entry 2 Risser Eric Blasius · CIK 0001587774 · Sr VP & Chief Business Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 2,497 shares Expires 2019-03-23 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transaction represents an exercise and hold of expiring options. Read SEC document |
| March 14, 2019 Filed Mar 18, 2019 20:36 UTC | MACROGENICS INC MGNX · Entity 6104 | Exercise / conversionCommon Stock | 2,497 | $0.94 | $2,347.18 |
DisclosureSEC source: 0001125345-19-000050 · wf-form4_155294139184437.xml · nonDerivative · entry 1 Risser Eric Blasius · CIK 0001587774 · Sr VP & Chief Business Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,806 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.